Stay updated on Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial
Sign up to get notified when there's something new on the Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial page.

Latest updates to the Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial page
- Check3 days agoChange DetectedAdded related topic 'Squamous cell carcinoma of the head and neck' and a Genetic and Rare Diseases Information Center (GARD) resource.SummaryDifference0.2%

- Check11 days agoNo Change Detected
- Check18 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.1%

- Check25 days agoChange Detected- Page revision updated from v3.4.2 to v3.4.3. No substantive changes to study details or eligibility.SummaryDifference0.1%

- Check54 days agoChange DetectedAdded Revision: v3.4.2 to the page and removed the older government funding status notices (Revision: v3.4.1).SummaryDifference0.4%

- Check61 days agoChange DetectedAdded a finalized Lancet publication citation for NIVOPOST-OP results and a government funding/status notice; the earlier ahead-of-print citation was replaced.SummaryDifference0.5%

- Check68 days agoChange DetectedUI and labeling updates: the glossary toggle is now shown, and small wording/casing changes were made to headers and revision information (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0).SummaryDifference0.2%

Stay in the know with updates to Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab with Cisplatin-RT in Head and Neck Cancers Clinical Trial page.